Dr. Michael Genovesi Steps Down as Chief Executive Officer

As of December 31, Dr. Michael Genovesi will relinquish his role as Chief Executive Officer. The Board of Directors is finalizing the selection of our new CEO and is currently evaluating our current leadership structure. An announcement will be made in early 2018.

Dr. Genovesi was instrumental in the initial conversations that opened the collaboration between Grove Hill and Connecticut Multispecialty Group. He had a vision for what the unity could bring and played a key role in facilitating the merger and subsequent integration.  Without his vision there would not be a Starling today.

Dr. Genovesi will continue as a pulmonologist throughout 2018 and then will officially retire from medicine. We are grateful for his many years of dedication and leadership.

Stay tuned for additional details about our leadership team and direction in the coming year.